Close Menu

NEW YORK – In a virtual presentation at the JP Morgan Healthcare Conference on Wednesday, Quidel CEO Doug Bryant punctuated $1.66 billion in projected full-year 2020 revenues with signaling a strategic move for the firm into a nascent over-the-counter infectious disease testing market.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.